Inlexisertib (DCC-3116)

Inlexisertib · Deciphera Pharmaceuticals, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Inlexisertib (DCC-3116), covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies [Phase 1, Phase 2]

See pricing